Could cause temporary or reversible harm; serious harm is unlikely.
Defective Delivery System: Possibility of no medication in the prefilled pen.
| Brand name | EXENATIDE |
| Generic name | EXENATIDE |
| Active ingredient(s) | EXENATIDE |
| Distributed by / for | Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 |
| NDC | 70121-1685-1 |
| Full product label | Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1 |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC |
| Distribution | USA Nationwide |
| Quantity | 5,694 pens |
| Recall initiated | 2026-08-28 |
| Report date | 2026-09-30 |
| Recall completed | — |
| Recall number | D-0868-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Brookhaven NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗